Why an Israeli company is developing an oral Covid vaccine

By Agence France-Presse

Aug 01, 2021 3:59 pm

WASHINGTON, D.C.: Imagine a Covid-19 vaccine that came as a pill: no needles, no medical professionals required to administer it, potentially delivered directly to people's homes.

Israeli pharmaceutical Oramed is attempting to accomplish just that, and is poised to start its first clinical trial in early August, CEO Nadav Kidron told Agence France-Presse in an interview.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Fewer storms hitting PH but more intense, dangerous – Pagasa

Security up amid threat to kill Marcos

Lopez transfer triggers fiery tirade from Duterte

President off to UAE for one-day work visit

'Hello, Love, Again' now PH's highest grossing film

UN: 343 million people 'acutely food insecure'

DOH: Dengue cases Oct 20-Nov 2 down 17%